Clinical evidence, including results from randomized controlled clinical trials, strongly suggests that certain live vaccines can reduce all-cause mortality, most probably through protection against non-targeted pathogens. This Opinion article examines the potential immunological mechanisms underlying these effects.
- Helen S. Goodridge
- S. Sohail Ahmed
- Christopher B. Wilson